Literature DB >> 29324226

Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo.

Eri Yamada1, Shinji Nakaoka2, Lukas Klein3, Elisabeth Reith3, Simon Langer3, Kristina Hopfensperger3, Shingo Iwami4, Gideon Schreiber5, Frank Kirchhoff3, Yoshio Koyanagi1, Daniel Sauter3, Kei Sato6.   

Abstract

The HIV-1-encoded accessory protein Vpu exerts several immunomodulatory functions, including counteraction of the host restriction factor tetherin, downmodulation of CD4, and inhibition of NF-κB activity to facilitate HIV-1 infection. However, the relative contribution of individual Vpu functions to HIV-1 infection in vivo remained unclear. Here, we used a humanized mouse model and HIV-1 strains with selective mutations in vpu to demonstrate that the anti-tetherin activity of Vpu is a prerequisite for efficient viral spread during the early phase of infection. Mathematical modeling and gain-of-function mutations in SIVcpz, the simian precursor of pandemic HIV-1, corroborate this finding. Blockage of interferon signaling combined with transcriptome analyses revealed that basal tetherin levels are sufficient to control viral replication. These results establish tetherin as a key effector of the intrinsic immune defense against HIV-1, and they demonstrate that Vpu-mediated tetherin antagonism is critical for efficient viral spread during the initial phase of HIV-1 replication.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; ISG; SIV; Vpu; humanized mouse; tetherin; type I interferon

Mesh:

Substances:

Year:  2018        PMID: 29324226     DOI: 10.1016/j.chom.2017.12.009

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  14 in total

1.  Polymorphisms in Rhesus Macaque Tetherin Are Associated with Differences in Acute Viremia in Simian Immunodeficiency Virus Δnef-Infected Animals.

Authors:  Sanath Kumar Janaka; Aidin Tavakoli-Tameh; William J Neidermyer; Ruth Serra-Moreno; James A Hoxie; Ronald C Desrosiers; R Paul Johnson; Jeffrey D Lifson; Steven M Wolinsky; David T Evans
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

2.  Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.

Authors:  Elena Heusinger; Katja Deppe; Paola Sette; Christian Krapp; Dorota Kmiec; Silvia F Kluge; Preston A Marx; Cristian Apetrei; Frank Kirchhoff; Daniel Sauter
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

3.  Vpu modulates DNA repair to suppress innate sensing and hyper-integration of HIV-1.

Authors:  Lisa Wiesmüller; Frank Kirchhoff; Meta Volcic; Konstantin M J Sparrer; Lennart Koepke; Dominik Hotter; Daniel Sauter; Christina M Stürzel; Myriam Scherer; Thomas Stamminger; Thomas G Hofmann; Nathalie J Arhel
Journal:  Nat Microbiol       Date:  2020-07-20       Impact factor: 17.745

4.  Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2.

Authors:  Kristina Hopfensperger; Jonathan Richard; Christina M Stürzel; Frederic Bibollet-Ruche; Richard Apps; Marie Leoz; Jean-Christophe Plantier; Beatrice H Hahn; Andrés Finzi; Frank Kirchhoff; Daniel Sauter
Journal:  mBio       Date:  2020-07-14       Impact factor: 7.867

5.  Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses.

Authors:  Jérémie Prévost; Suzanne Pickering; Mitchell J Mumby; Halima Medjahed; Gabrielle Gendron-Lepage; Gloria G Delgado; Brennan S Dirk; Jimmy D Dikeakos; Christina M Stürzel; Daniel Sauter; Frank Kirchhoff; Frederic Bibollet-Ruche; Beatrice H Hahn; Mathieu Dubé; Daniel E Kaufmann; Stuart J D Neil; Andrés Finzi; Jonathan Richard
Journal:  mBio       Date:  2019-06-18       Impact factor: 7.867

6.  HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses.

Authors:  Simon Langer; Christian Hammer; Kristina Hopfensperger; Lukas Klein; Dominik Hotter; Paul D De Jesus; Kristina M Herbert; Lars Pache; Nikaïa Smith; Johannes A van der Merwe; Sumit K Chanda; Jacques Fellay; Frank Kirchhoff; Daniel Sauter
Journal:  Elife       Date:  2019-02-05       Impact factor: 8.140

7.  CpG Frequency in the 5' Third of the env Gene Determines Sensitivity of Primary HIV-1 Strains to the Zinc-Finger Antiviral Protein.

Authors:  Dorota Kmiec; Rayhane Nchioua; Scott Sherrill-Mix; Christina M Stürzel; Elena Heusinger; Elisabeth Braun; Marcos V P Gondim; Dominik Hotter; Konstantin M J Sparrer; Beatrice H Hahn; Daniel Sauter; Frank Kirchhoff
Journal:  mBio       Date:  2020-01-14       Impact factor: 7.867

8.  Loss of tetherin antagonism by Nef impairs SIV replication during acute infection of rhesus macaques.

Authors:  Aidin Tavakoli-Tameh; Sanath Kumar Janaka; Katie Zarbock; Shelby O'Connor; Kristin Crosno; Saverio Capuano; Hajime Uno; Jeffrey D Lifson; David T Evans
Journal:  PLoS Pathog       Date:  2020-04-17       Impact factor: 7.464

9.  Site-Specific Evolutionary Rate Shifts in HIV-1 and SIV.

Authors:  Maoz Gelbart; Adi Stern
Journal:  Viruses       Date:  2020-11-16       Impact factor: 5.048

10.  A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humans.

Authors:  Yusuke Nakano; Keisuke Yamamoto; Mahoko Takahashi Ueda; Andrew Soper; Yoriyuki Konno; Izumi Kimura; Keiya Uriu; Ryuichi Kumata; Hirofumi Aso; Naoko Misawa; Shumpei Nagaoka; Soma Shimizu; Keito Mitsumune; Yusuke Kosugi; Guillermo Juarez-Fernandez; Jumpei Ito; So Nakagawa; Terumasa Ikeda; Yoshio Koyanagi; Reuben S Harris; Kei Sato
Journal:  PLoS Pathog       Date:  2020-09-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.